Is microcirculatory assessment ready for regular use in clinical practice?

被引:30
|
作者
De Backer, Daniel [1 ]
机构
[1] Univ Libre Bruxelles, CHIREC Hosp, Dept Intens Care, Brussels, Belgium
关键词
glycocalyx; microcirculation; tissue perfusion; venoarterial PCO2 gradients; videomicroscopy; SEPTIC SHOCK; SUBLINGUAL MICROCIRCULATION; ORGAN FAILURE; SEVERE SEPSIS; BLOOD-FLOW; REACTIVITY; TARGET; TIME;
D O I
10.1097/MCC.0000000000000605
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose of review The present review discusses the current role of microcirculatory assessment in the hemodynamic monitoring of critically ill patients. Recent findings Videomicroscopic techniques have demonstrated that microvascular perfusion is altered in critically ill patients, and especially in sepsis. These alterations are associated with organ dysfunction and poor outcome. Handheld microscopes can easily be applied on the sublingual area of critically ill patients. Among the specific limitations of these techniques, the most important is that these can mostly investigate the sublingual microcirculation. The representativity of the sublingual area may be questioned, especially as some areas may sometimes be more affected than the sublingual area. Also, evaluation of the sublingual area may be difficult in nonintubated hypoxemic patients. Alternative techniques include vasoreactivity tests using either transient occlusion or performing a thermal challenge. These techniques evaluate the maximal dilatory properties of the microcirculation but do not really evaluate the actual microvascular perfusion. Focusing on the glycocalyx may be another option, especially with biomarkers of glycocalyx degradation and shedding. Evaluation of the glycocalyx is still largely experimental, with different tools still in investigation and lack of therapeutic target. Venoarterial differences in PCO2 are inversely related with microvascular perfusion, and can thus be used as surrogate for microcirculation assessment. Several limitations prevent the regular use in clinical practice. The first is the difficult use of some of these techniques outside research teams, whereas nurse-driven measurements are probably desired. The second important limitation for daily practice use is the lack of uniformly defined endpoint. The final limitation is that therapeutic interventions affecting the microcirculation are not straightforward. Summary Clinical and biological surrogates of microcirculatory assessment can be used at bedside. The role of microvideoscopic techniques is still hampered by the lack of clearly defined targets as well as interventions specifically targeting the microcirculation.
引用
收藏
页码:280 / 284
页数:5
相关论文
共 50 条
  • [1] Microcirculatory assessment in daily clinical practice not yet ready but not too far!
    Salgado, Diamantino Ribeiro
    Favory, Raphael
    De Backer, Daniel
    EINSTEIN-SAO PAULO, 2010, 8 (01): : 107 - 116
  • [2] Is BNP ready for use in clinical practice?
    Khan, K
    HEART, 1999, 82 (02) : 254 - 255
  • [3] Is BNP ready for use in clinical practice? Reply
    Richards, AM
    Nicholls, MG
    Yandle, TG
    HEART, 1999, 82 (02) : 255 - 255
  • [4] Are appropriateness criteria ready for use in clinical practice?
    Shekelle, PG
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (09): : 677 - 678
  • [5] BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?
    Puxeddu, Efisio
    Filetti, Sebastiano
    ENDOCRINE, 2014, 45 (03) : 341 - 343
  • [6] BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?
    Efisio Puxeddu
    Sebastiano Filetti
    Endocrine, 2014, 45 : 341 - 343
  • [7] Are we ready to use oxidative stress in clinical practice?
    Grabowski, Marcin
    EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2013, 115 (02) : 133 - 135
  • [8] Fluorescence cystoscopy: is it ready for use in routine clinical practice?
    Spiess, Philippe E.
    Grossman, H. Barton
    CURRENT OPINION IN UROLOGY, 2006, 16 (05) : 372 - 376
  • [9] Are we ready to use TMB in breast cancer clinical practice?
    Ravaioli, Sara
    Limarzi, Francesco
    Tumedei, Maria Maddalena
    Palleschi, Michela
    Maltoni, Roberta
    Bravaccini, Sara
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (10) : 1943 - 1945
  • [10] Exoskeletons in MS rehabilitation are ready for widespread use in clinical practice: No
    Swinnen, Eva
    De Keersmaecker, Emma
    Beckwee, David
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (11) : 1669 - 1670